✦ LIBER ✦

Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids

✍ Scribed by Jan J. Stepan; Eva Havrdová; Michaela Týblová; Dana Horáková; Veronika Tichá; Iveta Nováková; Vı́t Zikán

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention of Bone Loss with Risedronate

✍ R. Eastell; J.-P. Devogelaer; N. F. A. Peel; A. A. Chines; D. E. Bax; N. Sacco-G 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 84 KB

Variable efficacy of bone remodeling bio

✍ C. de la Piedra, A. Rapado, E. M. Díaz Diego… 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 583 KB

Immediate Fall of Bone Formation and Tra

✍ Dovio, Andrea; Perazzolo, Laura; Osella, Giangiacomo; Ventura, Massimo; Termine, 📂 Article 📅 2004 🏛 Endocrine Society 🌐 English ⚖ 185 KB

Correlations between biochemical markers

✍ Alan L. Burshell; Rüdiger Möricke; Ricardo Correa-Rotter; Peiqi Chen; Margaret R 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 502 KB

Effect of alendronate on bone metabolic

✍ H. Kaji; Y. Kuroki; Y. Murakawa; I. Funakawa; Y. Funasaka; F. Kanda; T. Sugimoto 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 499 KB

Long-term effects of intravenous high do

✍ M. Zorzon; R. Zivadinov; L. Locatelli; D. Giuntini; M. Toncic; A. Bosco; D. Nasu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB